Bill Wilson, MD: Drug Shortage Lets Pharmacies Compound $1.5K Meds for $150—But Not for Long
During FDA-declared drug shortages, pharmacies can legally compound diabetes medications for $150 to $200 a month instead of $1,500 to $2,000. Once the shortage ends, compounding stops and patients face full branded prices again.
Questions this video answers
Patients with type 2 diabetes or some sign of insulin resistance.
About $150–$200 per month.
Branded drugs cost "thousands of dollars a month" and the speaker cites an example of $2,000 per month if prices rise.
The U.S. Food and Drug Administration (FDA).
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet